Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherShares Repurchased
Ratios

Corcept Therapeutics (CORT) Receivables - Other (2019 - 2025)

Corcept Therapeutics' Receivables - Other history spans 7 years, with the latest figure at $4.1 million for Q4 2025.

  • For Q4 2025, Receivables - Other changed 0.0% year-over-year to $4.1 million; the TTM value through Dec 2025 reached $4.1 million, changed 0.0%, while the annual FY2025 figure was $4.1 million, 0.0% changed from the prior year.
  • Receivables - Other for Q4 2025 was $4.1 million at Corcept Therapeutics, up from $3.9 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $18.2 million in Q1 2025 and bottomed at $600000.0 in Q2 2023.
  • The 5-year median for Receivables - Other is $1.8 million (2021), against an average of $4.4 million.
  • The largest annual shift saw Receivables - Other soared 1455.56% in 2023 before it crashed 79.29% in 2024.
  • A 5-year view of Receivables - Other shows it stood at $1.4 million in 2021, then rose by 28.57% to $1.8 million in 2022, then soared by 677.78% to $14.0 million in 2023, then plummeted by 70.71% to $4.1 million in 2024, then changed by 0.0% to $4.1 million in 2025.
  • Per Business Quant, the three most recent readings for CORT's Receivables - Other are $4.1 million (Q4 2025), $3.9 million (Q3 2025), and $4.1 million (Q2 2025).